PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System

Abstract Background Diabetes-induced oxidative stress has an essential role in pancreatic cells dysfunction. The present study aimed to evaluate whether peroxisome proliferator activated receptor- alpha (PPAR-α) induction by fenofibrate counterbalances oxidative stress in pancreatic cells. Methods In this in vivo study, male Wistar rats were randomly divided into four groups as normal, normal treated, diabetic and diabetic treated groups (n=6 in each group). Diabetes was induced by a single intravenous injection of streptozotocin (45 mg/kg). Treated animals received fenofibrate for 8 weeks (80 mg/kg/day) orally. At the end of the 8th week, rats were sacrificed and blood samples and pancreas tissues were collected. Then, the content of malondialdehyde (MDA), nitrate (Nox) and glutathione (GLT) and enzymatic activities of catalase (CAT) and superoxide dismutase (SOD) were assessed. D ata were analyzed using two-way ANOVA. Results Diabetes deteriorated anti-oxidant defense capacity in pancreatic cells by reducing SOD and CAT activities and induced oxidative stress as reflected by increased MDA content and free radicals production (Nox content). Treatment by fenofibrate increased SOD and CAT activities and improved oxidative stress by decreasing pancreatic MDA and Nox levels. Conclusion Uncontrolled hyperglycemia weakens anti-oxidant defense capacity in pancreatic cells and contributes to oxidative stress. PPAR-α induction by fenofibrate can restore anti-oxidant defense systems and improve diabetes-induced oxidative stress.

[1]  G. Rutter,et al.  The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. , 2017, Antioxidants & redox signaling.

[2]  A. Sahebkar,et al.  Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials , 2017, BMC Medicine.

[3]  A. Sahebkar,et al.  Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials. , 2016, Pharmacological research.

[4]  Caroline Pereira Domingueti,et al.  Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. , 2016, Journal of diabetes and its complications.

[5]  Min Jiang,et al.  Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3. , 2016, Biochemical and biophysical research communications.

[6]  J. Prins,et al.  Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes. , 2016, Journal of molecular endocrinology.

[7]  M. Beal,et al.  Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo. , 2016, Human molecular genetics.

[8]  A. Sahebkar,et al.  Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials. , 2015, Pharmacological research.

[9]  Hyeyoung Kim,et al.  Oxidative stress and inflammatory signaling in cerulein pancreatitis. , 2014, World journal of gastroenterology.

[10]  A. Sahebkar,et al.  Role of selective peroxisome proliferator‐activated receptor modulators in managing cardiometabolic disease: tale of a roller‐coaster , 2014 .

[11]  Jian-xing Ma,et al.  Salutary Effect of Fenofibrate on Diabetic Retinopathy via Inhibiting Oxidative Stress-mediated Wnt Pathway Activation , 2014 .

[12]  G. Watts,et al.  New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease , 2014, Expert opinion on pharmacotherapy.

[13]  A. Sahebkar,et al.  Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. , 2013, Atherosclerosis.

[14]  R. Sutton,et al.  Oxidative stress in acute pancreatitis: lost in translation? , 2013, Free radical research.

[15]  R. Eckel,et al.  Fenofibrate Improves Vascular Endothelial Function by Reducing Oxidative Stress While Increasing Endothelial Nitric Oxide Synthase in Healthy Normolipidemic Older Adults , 2012, Hypertension.

[16]  W. Park,et al.  Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells , 2012, Radiation oncology journal.

[17]  Xiaowei Liu,et al.  Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels , 2010, Brain Research.

[18]  Fei Wang,et al.  PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity. , 2010, Biochemical and biophysical research communications.

[19]  Ying Sun,et al.  Chronic palmitate exposure inhibits AMPKα and decreases glucose-stimulated insulin secretion from β-cells: modulation by fenofibrate , 2008, Acta Pharmacologica Sinica.

[20]  R. Robertson,et al.  Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. , 2006, Free radical biology & medicine.

[21]  T. Nakajima,et al.  Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[22]  Z. Varghese,et al.  PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice. Commentary , 2006 .

[23]  N. Komai,et al.  NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. , 2005, American journal of physiology. Renal physiology.

[24]  R. Robertson.  Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[25]  H. Kaneto,et al.  Role of Oxidative Stress in Pancreatic β‐Cell Dysfunction , 2004 .

[26]  N. Vaziri,et al.  Dysregulation of Hepatic Superoxide Dismutase, Catalase and Glutathione Peroxidase in Diabetes: Response to Insulin and Antioxidant Therapies , 2004, Clinical and experimental hypertension.

[27]  T. Aboushousha,et al.  Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes. , 2002, Journal of the Egyptian Society of Parasitology.

[28]  S. Bonner-Weir,et al.  Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression* , 2002, The Journal of Biological Chemistry.

[29]  Y. Soon,et al.  Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. , 2002, Singapore medical journal.

[30]  B. Topp,et al.  Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. , 2001, Diabetes.

[31]  J. Scoazec,et al.  Differential upregulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis. , 2001, The Journal of surgical research.

[32]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[33]  B. Xu,et al.  Overexpression of catalase provides partial protection to transgenic mouse beta cells. , 1999, Free radical biology & medicine.

[34]  Y. Bardak,et al.  Superoxide Dismutase, Catalase, Glutathione Peroxidase and Xanthine Oxidase in Diabetic Rat Lenses , 1999, Ophthalmic Research.

[35]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[36]  S. Marklund,et al.  CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. , 1981, The Biochemical journal.

[37]  R. Carrell,et al.  The estimation of red cell superoxide dismutase activity. , 1975, The Journal of laboratory and clinical medicine.

[38]  F. Tietze.  Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.

[39]  M. Pencina,et al.  Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. , 2016, Pharmacological research.

[40]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[41]  Jerrold M. Olefsky,et al.  Diabetes mellitus : a fundamental and clinical text , 2004 .

[42]  K. Boockvar,et al.  Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. , 1996, Methods in enzymology.

[43]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.

[44]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.